ARCHIVES

NCI Proposal Would Give Drug Sponsors Commercial Rights To Biomarker Inventions

This article is from The Cancer Letter archive.

Vol. 35 No. 38 | October 16, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Alfred Ketcham Is New SSO President; Meyskens Receives NCI Year 2000 Award; Colman Honored

August 10, 1990

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

May 27, 2005

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

March 16, 2007

Civin Moves From Hopkins To Maryland To Direct Stem Cell Medicine Center

January 9, 2009

Senators Tie Medicare Oral Drug Payment to Ending Markup on Infused Drugs

March 22, 2002

Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia

May 25, 2007